These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 20226660)

  • 1. First synthesis of separable isomeric testosterone dimers showing differential activities on prostate cancer cells.
    Bastien D; Leblanc V; Asselin E; Bérubé G
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2078-81. PubMed ID: 20226660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of androgen receptor full antagonists bearing a p-carborane cage: promising ligands for anti-androgen withdrawal syndrome.
    Goto T; Ohta K; Fujii S; Ohta S; Endo Y
    J Med Chem; 2010 Jul; 53(13):4917-26. PubMed ID: 20521823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative C
    Paquin A; Oufqir Y; Sevrioukova IF; Reyes-Moreno C; Bérubé G
    Eur J Med Chem; 2021 Aug; 220():113496. PubMed ID: 33933755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and preliminary in vitro biological evaluation of 7α-testosterone-chlorambucil hybrid designed for the treatment of prostate cancer.
    Bastien D; Hanna R; Leblanc V; Asselin É; Bérubé G
    Eur J Med Chem; 2013 Jun; 64():442-7. PubMed ID: 23665800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of bioisosteric replacement of the carboxylic acid in novel androgen receptor pure antagonists.
    Yoshino H; Sato H; Tachibana K; Shiraishi T; Nakamura M; Ohta M; Ishikura N; Nagamuta M; Onuma E; Nakagawa T; Arai S; Ahn KH; Jung KY; Kawata H
    Bioorg Med Chem; 2010 May; 18(9):3159-68. PubMed ID: 20381361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide.
    Payen O; Top S; Vessières A; Brulé E; Plamont MA; McGlinchey MJ; Müller-Bunz H; Jaouen G
    J Med Chem; 2008 Mar; 51(6):1791-9. PubMed ID: 18303829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel C
    Vesper AR; Lacroix J; C-Gaudreault R; Tajmir-Rihai HA; Bérubé G
    Steroids; 2016 Nov; 115():98-104. PubMed ID: 27553724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin mediates resistance to antiandrogen therapy in prostate cancer.
    Zhang M; Latham DE; Delaney MA; Chakravarti A
    Oncogene; 2005 Apr; 24(15):2474-82. PubMed ID: 15735703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors.
    Urushibara M; Ishioka J; Hyochi N; Kihara K; Hara S; Singh P; Isaacs JT; Kageyama Y
    Prostate; 2007 Jun; 67(8):799-807. PubMed ID: 17373727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical synthesis and biological activities of 16alpha-derivatives of 5alpha-androstane-3alpha,17beta-diol as antiandrogens.
    Roy J; Breton R; Martel C; Labrie F; Poirier D
    Bioorg Med Chem; 2007 Apr; 15(8):3003-18. PubMed ID: 17336533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of androgen receptor antagonists with bulky side chains for overcoming antiandrogen resistance.
    Zhou J; Geng G; Shi Q; Sauriol F; Wu JH
    J Med Chem; 2009 Sep; 52(17):5546-50. PubMed ID: 19725582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New testosterone derivatives as semi-synthetic anticancer agents against prostate cancer: synthesis and preliminary biological evaluation.
    Morin N; Bruneau J; Fortin S; Brasseur K; Leblanc V; Asselin E; Berube G
    Med Chem; 2015; 11(6):531-9. PubMed ID: 25675439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computationally identified novel diphenyl- and phenylpyridine androgen receptor antagonist structures.
    Söderholm AA; Viiliäinen J; Lehtovuori PT; Eskelinen H; Roell D; Baniahmad A; Nyrönen TH
    J Chem Inf Model; 2008 Sep; 48(9):1882-90. PubMed ID: 18712859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating a new C2-symmetric testosterone dimer and its dihydrotestosterone analog: Synthesis, antiproliferative activity on prostate cancer cell lines and interaction with CYP3A4.
    Paquin A; Fortin L; Girouard J; Reyes-Moreno C; Sevrioukova IF; Bérubé G
    Eur J Med Chem; 2023 Mar; 250():115222. PubMed ID: 36848848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 9,11-Secosterols with antiproliferative activity from the gorgonian Eunicella cavolini.
    Ioannou E; Abdel-Razik AF; Alexi X; Vagias C; Alexis MN; Roussis V
    Bioorg Med Chem; 2009 Jul; 17(13):4537-41. PubMed ID: 19467602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure and synthesis of 17 alpha-(5-bromovaleroyloxy)-16 beta-methylpregna-4,6-diene-3,20-dione.
    Soriano-García M; Ramírez E; Bratoeff E; Cabeza M; Aguirre-Hernández G
    Anal Sci; 2001 Jul; 17(7):911-2. PubMed ID: 11708132
    [No Abstract]   [Full Text] [Related]  

  • 17. Piper cubeba targets multiple aspects of the androgen-signalling pathway. A potential phytotherapy against prostate cancer growth?
    Yam J; Kreuter M; Drewe J
    Planta Med; 2008 Jan; 74(1):33-8. PubMed ID: 18080233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
    Fujimoto N; Miyamoto H; Mizokami A; Harada S; Nomura M; Ueta Y; Sasaguri T; Matsumoto T
    Cancer Invest; 2007 Feb; 25(1):32-7. PubMed ID: 17364555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate specific antigen expression does not necessarily correlate with prostate cancer cell growth.
    Peternac D; Klima I; Cecchini MG; Studer UE; Thalmann GN
    J Urol; 2006 Jul; 176(1):354-60. PubMed ID: 16753443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential androgen modulation of AXC/SSh rat prostate cancer cell proliferation in vitro and its antagonism by antiandrogen.
    Huot RI; Shain SA
    Cancer Res; 1986 Aug; 46(8):3775-81. PubMed ID: 2942235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.